Clinical Trials Browser

Phase 2 × Histiocytosis, Langerhans-Cell × Lenalidomide × Clear all

NCT02523040 2025-12-10

Lenalidomide for Adult Histiocyte Disorders

Phase 2 Active not recruiting

12 enrolled 14 charts

Histiocytosis, Langerhans-Cell, Erdheim-Chester Disease, Histiocytic Sarcoma